ABBV
AbbVie, Inc. · NYSE
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website abbvie.com
- Employees(FY) 50000
- ISIN US00287Y1091
Performance
+3.75%
1W
+2.39%
1M
-5.34%
3M
+22.66%
6M
+9.45%
YTD
+20.83%
1Y
Profile
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; California Institute for Biomedical Research (Calibr), and BigHat Biosciences, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Investment Analysis Report: ABBV
Overview:
AbbVie Inc. (ABBV) operates in the Health Technology sector, specifically in the Pharmaceuticals: Major industry. The company has a market capitalization of $314.59 billion. In this report, we will conduct a detailed analysis of ABBV's financial health, valuation, earnings and revenue growth, profitabil...
Technical Analysis of ABBV 2024-05-10
Overview:
In analyzing the technical indicators for ABBV over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible stock price movement. By examining key indicators such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to offer valuable insights...
Recent News & Updates
- 2024-05-17 19:11
7 Value Stocks to Buy and Hold for a Decade of Dominance(Investorplace)
- 2024-05-17 09:38
- 2024-05-17 07:30
- 2024-05-17 03:30
AbbVie CEO latest heavy hitter to buy in Boca Raton(Yahoo Finance)
- 2024-05-16 19:30
- 2024-05-16 11:45
- 2024-05-15 18:00
- 2024-05-15 06:22
NeuroSense taps PhaseV’s ML tech for Phase III ALS trial analysis(Clinical Trials Arena)
- 2024-05-15 00:10
- 2024-05-14 21:00
- 2024-05-14 12:10
- 2024-05-14 09:00
- 2024-05-14 06:30
- 2024-05-14 04:51
- 2024-05-13 20:00
Unlocking Intrinsic Value: Analysis of AbbVie Inc(Yahoo Finance)
- 2024-05-13 11:44
12 Undervalued Stocks That Just Raised Their Dividends(Insider Monkey)
- 2024-05-13 11:09
What Is the Dividend Payout for AbbVie Stock?(Motley Fool)
- 2024-05-13 09:34
- 2024-05-13 08:38
- 2024-05-12 20:39
- 2024-05-11 17:00
- 2024-05-11 08:38
Earn $1000 Every Month From These 3 Stocks(Motley Fool)
- 2024-05-11 03:50
- 2024-05-11 00:59
- 2024-05-10 11:16
- 2024-05-10 09:30
- 2024-05-10 03:53
- 2024-05-09 07:11
Q1 2024 Regenxbio Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-05-08 14:10
- 2024-05-08 10:49
Page 1 of 10
previousnext